tm
Seeing Is Believing
tm
Seeing Is Believing
ONCT is currently covered by 4 analysts
Oncternal Therapeutics's activity chart (see below) currently has 2 price targets and 17 ratings on display. The stock rating distribution of ONCT is 61.54% BUY and 38.46% HOLD.
Analysts average stock forecasts to be materialized ratio is 22.86% with an average time for these price targets to be met of 40.6 days.
Highest price target for ONCT is $18, Lowest price target is $4.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 12-Aug-2024. First documented stock forecast 10-Aug-2020.
Currently out of the existing stock ratings of ONCT, 8 are a BUY (61.54%), 5 are a HOLD (38.46%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$18
$16.86 (1478.95%)
$19
2 years 27 days ago
(12-Aug-2024)
1/7 (14.29%)
$13.83 (331.65%)
190
Buy
$2
$-5.6 (-73.68%)
2 years 9 months 4 days ago
(04-Dec-2023)
0/1 (0%)
$-5 (-71.43%)
Hold
$26
$24.86 (2180.70%)
3 years 1 days ago
(07-Sep-2023)
0/2 (0%)
$20 (333.33%)
Hold
$70
3 years 5 months 4 days ago
(04-Apr-2023)
0/1 (0%)
$50 (250.00%)
Hold
$9
3 years 5 months 4 days ago
(04-Apr-2023)
1/1 (100%)
$-5.2 (-36.62%)
13
What is ONCT (Oncternal Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on ONCT (Oncternal Therapeutics)?
Which analyst has the current lower performing score on ONCT (Oncternal Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ONCT (Oncternal Therapeutics)?
Which analyst is the currently most bullish on ONCT (Oncternal Therapeutics)?
Which analyst is the currently most reserved on ONCT (Oncternal Therapeutics)?
